Literature DB >> 9139721

Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest.

M C Horne1, K L Donaldson, G L Goolsby, D Tran, M Mulheisen, J W Hell, A F Wahl.   

Abstract

Human cyclin G2 together with its closest homolog cyclin G1 defines a novel family of cyclins (Horne, M. C., Goolsby, G. L., Donaldson, K. L., Tran, D., Neubauer, M., and Wahl, A. F. (1996) J. Biol. Chem. 271, 6050-6061). Cyclin G2 is highly expressed in the immune system where immunologic tolerance subjects self-reactive lymphocytes to negative selection and clonal deletion via apoptosis. Here we investigated the effect of growth inhibitory signals on cyclin G2 mRNA abundance in different maturation stage-specific murine B cell lines. Upon treatment of wild-type and p53 null B cell lines with the negative growth factor, transforming growth factor beta1, or the growth inhibitory corticosteroid dexamethasone, cyclin G2 mRNA levels were increased in a time-dependent manner 5-14-fold over control cell levels. Unstimulated immature B cell lines (WEHI-231 and CH31) and unstimulated or IgM B cell receptor (BCR) -stimulated mature B cell lines (BAL-17 and CH12) rapidly proliferate and express low levels of cyclin G2 mRNA. In contrast, BCR-stimulated immature B cell lines undergo growth arrest and coincidentally exhibit an approximately 10-fold increase in cyclin G2 transcripts and a decrease in cyclin D2 message. Costimulation of WEHI-231 and CH31 cells with calcium ionophores and protein kinase C agonists partially mimics anti-IgM stimulation and elicits a strong up-regulation of cyclin G2 mRNA and down-regulation of cyclin D2 mRNA. Signaling mutants of WEHI-231 that are deficient in the phosphoinositide signaling pathway and consequently resistant to the BCR stimulus-induced growth arrest did not display a significant increase in cyclin G2 or decrease in cyclin D2 mRNAs when challenged with anti-IgM antibodies. The two polyclonal activators lipopolysaccharide and soluble gp39, which inhibit the growth arrest response of immature B cells, suppressed cyclin G2 mRNA expression induced by BCR stimulation. These results suggest that in murine B cells responding to growth inhibitory stimuli cyclin G2 may be a key negative regulator of cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9139721     DOI: 10.1074/jbc.272.19.12650

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Transcriptomic classification of antitumor agents: application to the analysis of the antitumoral effect of SR31747A.

Authors:  Jean-Bernard Ferrini; Omar Jbilo; Annick Peleraux; Therese Combes; Hubert Vidal; Sylvaine Galiegue; Pierre Casellas
Journal:  Gene Expr       Date:  2003

2.  Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a p53-dependent cell cycle arrest.

Authors:  Aruni S Arachchige Don; Robert F Dallapiazza; David A Bennin; Tiffany Brake; Colleen E Cowan; Mary C Horne
Journal:  Exp Cell Res       Date:  2006-09-29       Impact factor: 3.905

3.  Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival.

Authors:  Maike Zimmermann; Aruni P S Arachchige-Don; Michaela S Donaldson; Tommaso Patriarchi; Mary C Horne
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

4.  Dual role of SnoN in mammalian tumorigenesis.

Authors:  Qingwei Zhu; Ariel R Krakowski; Elizabeth E Dunham; Long Wang; Abhik Bandyopadhyay; Rebecca Berdeaux; G Steven Martin; LuZhe Sun; Kunxin Luo
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

5.  Changes in the expression of cyclin G2 in esophageal cancer cell and its significance.

Authors:  J Q Chen; C J Liu; H X Wen; C L Shi; H S Zhang; M Li; G G Sun
Journal:  Tumour Biol       Date:  2013-12-03

6.  Effect of cyclin G2 on proliferative ability of prostate cancer PC-3 cell.

Authors:  D W Cui; Y J Cheng; S W Jing; G G Sun
Journal:  Tumour Biol       Date:  2013-11-29

7.  Effect of cyclin G2 on proliferative ability of SGC-7901 cell.

Authors:  Jie Liu; Ze-Shi Cui; Yang Luo; Li Jiang; Xiao-Hui Man; Xue Zhang
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

8.  Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7.

Authors:  Guoxiong Xu; Stefanie Bernaudo; Guodong Fu; Daniel Y Lee; Burton B Yang; Chun Peng
Journal:  Mol Biol Cell       Date:  2008-09-10       Impact factor: 4.138

9.  TATA-binding protein-like protein (TLP/TRF2/TLF) negatively regulates cell cycle progression and is required for the stress-mediated G(2) checkpoint.

Authors:  Miho Shimada; Tomoyoshi Nakadai; Taka-Aki Tamura
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

10.  Overexpression of transcription factor Sp1 leads to gene expression perturbations and cell cycle inhibition.

Authors:  Emmanuelle Deniaud; Joël Baguet; Roxane Chalard; Bariza Blanquier; Lilia Brinza; Julien Meunier; Marie-Cécile Michallet; Aurélie Laugraud; Claudette Ah-Soon; Anne Wierinckx; Marc Castellazzi; Joël Lachuer; Christian Gautier; Jacqueline Marvel; Yann Leverrier
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.